ATA945174A - Verfahren zur herstellung neuer ergopeptin- derivate - Google Patents

Verfahren zur herstellung neuer ergopeptin- derivate

Info

Publication number
ATA945174A
ATA945174A AT945174A AT945174A ATA945174A AT A945174 A ATA945174 A AT A945174A AT 945174 A AT945174 A AT 945174A AT 945174 A AT945174 A AT 945174A AT A945174 A ATA945174 A AT A945174A
Authority
AT
Austria
Prior art keywords
producing new
ergopeptin
derivatives
ergopeptin derivatives
producing
Prior art date
Application number
AT945174A
Other languages
English (en)
Other versions
AT352911B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT1878A priority Critical patent/AT368154B/de
Publication of ATA945174A publication Critical patent/ATA945174A/de
Application granted granted Critical
Publication of AT352911B publication Critical patent/AT352911B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
AT945174A 1973-11-28 1974-11-26 Verfahren zur herstellung neuer ergopeptin- derivate AT352911B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT1878A AT368154B (de) 1973-11-28 1978-01-03 Verfahren zur herstellung neuer lysergsaeurederivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1669873A CH587858A5 (de) 1973-11-28 1973-11-28

Publications (2)

Publication Number Publication Date
ATA945174A true ATA945174A (de) 1979-03-15
AT352911B AT352911B (de) 1979-10-10

Family

ID=4419482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT945174A AT352911B (de) 1973-11-28 1974-11-26 Verfahren zur herstellung neuer ergopeptin- derivate

Country Status (25)

Country Link
US (1) US4229451A (de)
JP (1) JPS5919116B2 (de)
AT (1) AT352911B (de)
BE (1) BE822729A (de)
CA (1) CA1034572A (de)
CH (1) CH587858A5 (de)
CS (1) CS176291B2 (de)
DD (1) DD115119A5 (de)
DE (1) DE2454619A1 (de)
DK (1) DK143804C (de)
ES (1) ES432288A1 (de)
FI (1) FI59254C (de)
FR (2) FR2252098B1 (de)
GB (2) GB1496492A (de)
HK (1) HK54080A (de)
HU (1) HU168859B (de)
IE (1) IE41767B1 (de)
IL (1) IL46128A (de)
MY (1) MY8100185A (de)
NL (1) NL7415250A (de)
NO (1) NO744175L (de)
PH (1) PH13669A (de)
SE (2) SE417319B (de)
SU (1) SU516355A3 (de)
ZA (1) ZA747603B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH601321A5 (de) * 1975-01-06 1978-07-14 Sandoz Ag
CH619468A5 (de) * 1976-01-12 1980-09-30 Sandoz Ag
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
US20070197576A1 (en) * 2006-02-08 2007-08-23 Resolution Chemicals Limited Production of Cabergoline and Novel Polymorphic Form Thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2619488A (en) * 1952-11-25 Method of preparing d
DE1006425B (de) * 1954-04-07 1957-04-18 Sandoz Ag Verfahren zur Herstellung der isomeren racemischen Dihydrolysergsaeuren und ihren Homologen
GB769260A (en) * 1954-04-07 1957-03-06 Sandoz Ltd Process for the preparation of isomeric racemic dihydrolysergic acids and their homologues
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH469006A (de) * 1965-07-07 1969-02-28 Sandoz Ag Verfahren zur Herstellung neuer synthetischer Alkaloide
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
GB1298277A (en) * 1969-04-18 1972-11-29 Sandoz Ltd Preparation of ergot peptide alkaloids
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
CH601321A5 (de) * 1975-01-06 1978-07-14 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation

Also Published As

Publication number Publication date
NO744175L (de) 1975-06-23
DK143804C (da) 1982-03-29
CA1034572A (en) 1978-07-11
FI59254C (fi) 1981-07-10
FR2252098B1 (de) 1978-06-30
SE417319B (sv) 1981-03-09
HK54080A (en) 1980-10-03
IL46128A0 (en) 1975-02-10
NL7415250A (nl) 1975-05-30
DK143804B (da) 1981-10-12
GB1496492A (en) 1977-12-30
AU7582674A (en) 1976-05-27
SE7710418L (sv) 1977-09-16
HU168859B (de) 1976-07-28
CS176291B2 (de) 1977-06-30
CH587858A5 (de) 1977-05-13
IL46128A (en) 1977-10-31
FI334574A (de) 1975-05-29
JPS5919116B2 (ja) 1984-05-02
US4229451A (en) 1980-10-21
FR2334681B1 (de) 1980-04-18
ES432288A1 (es) 1977-02-16
SE424869B (sv) 1982-08-16
FR2334681A1 (fr) 1977-07-08
PH13669A (en) 1980-08-26
FR2252098A1 (de) 1975-06-20
DE2454619A1 (de) 1975-06-05
DD115119A5 (de) 1975-09-12
BE822729A (fr) 1975-05-28
SE7414607L (de) 1975-05-29
DK600374A (de) 1975-07-28
JPS5084599A (de) 1975-07-08
GB1496491A (en) 1977-12-30
AT352911B (de) 1979-10-10
ZA747603B (en) 1976-07-28
IE41767B1 (en) 1980-03-26
SU516355A3 (ru) 1976-05-30
MY8100185A (en) 1981-12-31
FI59254B (fi) 1981-03-31
IE41767L (en) 1975-05-28

Similar Documents

Publication Publication Date Title
AT343295B (de) Verfahren zur herstellung neuer haptensteroide
AT341118B (de) Verfahren zur herstellung neuer dotriacontapeptidamide
ATA208576A (de) Verfahren zur herstellung neuer alfa-athylbenzhydrol-derivate
AT337165B (de) Verfahren zur herstellung neuer phenylpropenylaminderivate
AT352911B (de) Verfahren zur herstellung neuer ergopeptin- derivate
AT332402B (de) Verfahren zur herstellung neuer 5-nitro-2-thiazolylthio-substituierter pyridinderivate
AT349460B (de) Verfahren zur herstellung neuer pyrazolderivate
AT356648B (de) Verfahren zur herstellung neuer indolderivate
AT334365B (de) Verfahren zur herstellung neuer thiazol-5-methanol-derivate
ATA924875A (de) Verfahren zur herstellung neuer 5-nitroimida- zolderivate
AT358065B (de) Verfahren zur herstellung neuer anhydrofuranosederivate
AT327388B (de) Verfahren zur herstellung neuer n-(benzolsulfonyl)-erythromycylaminderivate
AT332569B (de) Verfahren zur herstellung neuer piperazinderivate
DD108067A5 (de) Verfahren zur herstellung neuer bicycloalkan-derivate
AT336200B (de) Verfahren zur herstellung neuer cardenolidacetale
ATA986376A (de) Verfahren zur herstellung neuer haptensteroide
AT337691B (de) Verfahren zur herstellung neuer nitroimidazolderivate
AT332390B (de) Verfahren zur herstellung neuer benzimidazolderivate
AT345484B (de) Verfahren zur herstellung neuer dotriacontapeptidamide
ATA158875A (de) Verfahren zur herstellung neuer pseudotrisaccharide
ATA630474A (de) Verfahren zur herstellung neuer pyridazinderivate
AT355230B (de) Verfahren zur herstellung neuer vincamin- derivate
ATA652477A (de) Verfahren zur herstellung neuer vincaminderivate
AT332869B (de) Verfahren zur herstellung neuer benzofuran-derivate
AT357567B (de) Verfahren zur herstellung neuer anhydro- furanosederivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee